KEENEYE Revenue and Competitors
Estimated Revenue & Valuation
- KEENEYE's estimated annual revenue is currently $2.3M per year.
- KEENEYE's estimated revenue per employee is $188,500
Employee Data
- KEENEYE has 12 Employees.
- KEENEYE grew their employee count by -45% last year.
KEENEYE's People
| Name | Title | Email/Phone |
|---|
KEENEYE Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.3M | 20 | -23% | N/A | N/A |
#2 | $7.4M | 30 | N/A | N/A | N/A |
#3 | $16.4M | 59 | 0% | N/A | N/A |
#4 | $113.8M | 293 | 17% | N/A | N/A |
#5 | $48.8M | 143 | 15% | N/A | N/A |
#6 | $10.7M | 43 | 2% | N/A | N/A |
#7 | $3.3M | 18 | N/A | N/A | N/A |
#8 | $2.1M | 11 | -58% | N/A | N/A |
#9 | $14.6M | 52 | N/A | N/A | N/A |
#10 | $7.4M | 30 | 7% | N/A | N/A |
What Is KEENEYE?
We are the AI platform company that elevates computational pathology to guide better drug development and diagnostics. https://bit.ly/3bkHsXu
keywords:N/A
N/A
Total Funding
12
Number of Employees
$2.3M
Revenue (est)
-45%
Employee Growth %
N/A
Valuation
N/A
Accelerator
KEENEYE News
2022-04-20 - Chambers: Pavel Francouz injury from the bench is a shot across the bow for
reeling Avalanche
And they must keep a keen eye on the puck in play particularly when it becomes a threat to hit them in the head.
2022-04-19 - Maxwell Myers Obituary (1923 - 2022) - San Francisco, CA ...
... with his three children and repeatedly transforming the business by dint of his keen eye for opportunity and sense of San Francisco's changing pulse.
2022-03-30 - Keen Eye and Ultivue Announce Collaborative Agreement to ...
Keen Eye and Ultivue Announce Collaborative Agreement to Propel Multiplex and Spatial Analysis in Clinical Research. March 29, 2022 02:38 PM...
Other Companies in Paris
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1M | 12 | N/A | N/A |
#2 | $1M | 12 | N/A | N/A |
#3 | $1M | 12 | N/A | N/A |
#4 | $1M | 12 | N/A | N/A |
#5 | $1M | 12 | 9% | N/A |